PuraPharm Corporation Limited (HKG:1498)
Hong Kong · Delayed Price · Currency is HKD 0.2440
-0.0060 (-2.40%)
Sep 18, 2026, 2:08 PM HKT
PuraPharm Corporation Market Cap
PuraPharm Corporation has a market cap or net worth of 130.55 million as of September 18, 2026. Its market cap has decreased by -26.56% in one year.
Market Cap
130.55M
Enterprise Value
488.94M
Revenue
323.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.24
ChartMarket Cap Chart
Since July 8, 2015, PuraPharm Corporation's market cap has decreased from 861.75M to 130.55M, a decrease of -84.85%. That is a compound annual growth rate of -15.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 130.55M | -31.27% |
| Dec 31, 2025 | 189.94M | -12.58% |
| Dec 31, 2024 | 217.28M | -38.89% |
| Dec 29, 2023 | 355.55M | -29.69% |
| Dec 30, 2022 | 505.67M | 58.47% |
| Dec 31, 2021 | 319.09M | 19.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Zhongzhi Pharmaceutical Holdings | 621.79M |
| Fusen Pharmaceutical Company | 621.01M |
| Wai Yuen Tong Medicine Holdings | 412.32M |
| Regent Pacific Group | 261.18M |
| Tianda Pharmaceuticals | 258.01M |
| Extrawell Pharmaceutical Holdings | 243.60M |
| Kontafarma China Holdings | 190.01M |
| Shenzhen Neptunus Interlong Bio-technique Company | 167.80M |